US Health MOUs Spark Controversy Over Data & Sovereignty

Africa Questions Trump’s Health Diplomacy

THE US America First Global Health Strategy, a centerpiece of the Trump administration’s international policy, is under scrutiny as African nations grapple with the implications of the program. Launched in September 2025, the strategy promises direct funding to governments in lieu of NGO intermediaries—but several countries argue the deals are exploitative and threaten local control over health data.

Twenty African nations have signed MOUs so far, including Nigeria, Kenya, and Zambia. The agreements require recipient states to gradually finance their own health programs, while granting the US access to pathogen surveillance, disease outbreak data, and in some cases, mineral resources.

Aid With a Catch

While financial contributions are significant—Nigeria is slated to receive $2.1 billion and Kenya $1.63 billion—they are smaller than previous funding, averaging a 40 percent reduction from historical aid levels. In return, African states must commit to self-financing their health systems. Failure to meet conditions could result in withdrawal of future funding.

The strategy emphasizes global health security, claiming that faster access to outbreak data will allow the US to preempt pandemics and benefit domestic pharmaceutical companies. Critics contend that the focus on data collection over direct health delivery prioritizes American corporate and geopolitical interests above local populations.

Legal and Political Roadblocks

Zimbabwe withdrew from the program after government officials questioned the fairness of sharing health data without guaranteed access to resulting vaccines or treatments. Kenya’s High Court has paused its MOU amid challenges over patient data access, and Zambia has sought revisions to remove mineral-related clauses. The Democratic Republic of Congo and Guinea face similar tensions.

“This approach is essentially about mining health data for US benefit,” said Sophie Harman, International Politics Professor at Queen Mary University of London. “It bypasses multilateral oversight and prioritizes extraction over health equity.”

NGO Bypass Raises Concerns

The Trump administration’s sidelining of NGOs has also alarmed health experts. Kerry Cullinan of Health Policy Watch warned that excluding NGOs risks undermining care delivery, particularly for vulnerable populations. “Countries are being pressured to spend money on epidemiologists and data collection, rather than nurses or hospital equipment,” she said.

Strategic Implications

Observers argue the MOUs reflect a transactional style of diplomacy, combining aid, ideological conditions, and access to natural resources to consolidate US influence. Atilla Kisla of the Southern Africa Litigation Centre described it as a “geopolitical pivot,” designed to operate outside multilateral frameworks and ensure American dominance in global health data.

African governments now face a difficult choice: accept aid with strings attached or risk underfunded health systems. While the program seeks to reduce aid dependency and encourage domestic investment in health, the balance of benefits appears skewed toward the US. Countries must weigh sovereignty, ethical concerns, and urgent public health needs against the potential gains of foreign funding.